若年認知症支援ハンドブック_H19

Size: px

Start display at page:

Download "若年認知症支援ハンドブック_H19"

いっけいいなおか
5 years ago
Views:

6 ) - 1 -

7 ) ) , 5) 10 5) ) ) 2:1 4) - 2 -

8 1 24, 6) Harvey ) ) ) ) Alzheimer disease 9 11) posterior dementia β β E ε4-3 -

9 - - 4

10 frontotemporal dementia 12 15) fronto-temporal lobar degeneration progressive non-fluent aphasia semantic aphasia semantic dementia anterior dementia ) , 15) dementia with Lewy body 16, 17) α

11 1 1 18) 19) vascular dementia 20 22) 3) anoxic encephalopathy 23) - 6 -

12 B12 HIV MRI - 7 -

13 11) 17, 24) 14) SPECT Single Photon Emission Computed Tomography 123I 99 mtc - 25) 14, 26, 27) - 17, 28)PET Positron Emission Tomography SPECT SPECT Mini-Mental State Examination MMSE HDS-R Alzheimer s Disease Assessment Scale ADAS Wechsler Adult Intelligence Scale-Revised WAIS-R 2931) Wisconsin Card Sorting TestWCSTStroop test 23) Mental Function Impairment Scale MENFIS Functional Assessment Staging FAST Clinical Dementia Rating CDR 29) - 8 -

14 TPHA β 11, 32) 33) - 9 -

15 - 10-

16 - 11-

17 23, 34) - 12-

18 * 2 behavioral and psychological signs and symptoms of dementia BPSD

19 9, 11, 21, 23, 36) - 14-

20 1214, 21, 23, 26) 23, 34) 16, 17, 21) 2023) 3-15-

21 ) 10

22 - 17-

24 37, , 40 L

26 MRI

28 - 23 -

29 BPSD 3 (4) 45 ADL

30 - 25 -

31 - 26 -

32 5 47,

33 49,

35 - 30 -

36 , 55

37 6 47,

38 - 33 -

39 - 34 -

40 - 35 -

41 - 36 -

42 - 37 -

43 - 38 -

44 - 39 -

45 - 40 -

46 - 41 -

47 - 42 -

48 1) 2) 3)

49 F TEL FAX F TEL FAX asahikawa-ctr@jeed.or.jp TEL FAX aomori-ctr@jeed.or.jp TEL FAX iwate-ctr@jeed.or.jp TEL FAX miyagi-ctr@jeed.or.jp TEL FAX akita-ctr@jeed.or.jp TEL FAX yamagata-ctr@jeed.or.jp TEL FAX fukushima-ctr@jeed.or.jp TEL FAX ibaraki-ctr@jeed.or.jp TEL FAX tochigi-ctr@jeed.or.jp TEL FAX gunma-ctr@jeed.or.jp TEL FAX saitama-ctr@jeed.or.jp

50 TEL FAX F TEL FAX F TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX F TEL FAX F TEL FAX UFJ 6F TEL FAX TEL FAX

51 TEL FAX TEL FAX F TEL FAX F TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX TEL FAX

52 TEL FAX F TEL FAX TEL FAX TEL FAX TEL FAX F TEL FAX TEL FAX TEL FAX TEL FAX F TEL FAX )

53 - 48 -

54 - 49 -

55 ) )

56 , 4) % 5)

57 1 70 7) 3) )

60 2), 9) %

61 - 56 -

62 ) 11)-14) 15)

63 - 58 -

64 ) 12 9) 13 16)-24)

65 25), 26) 26)

68 - 63 -

69 - 64 -

70 A

71 ( 2 20 ) 2 ( ) 3 4 (1 6 ) 3 ( ) ( ) 1 ( ) 3 4 ( 30 1 ) ( )

72 B 40 ( ) 18 1 ( ) ( ) ( ) ( )

73 1 (70 ) 35,400 8,100 ( 267,000 )1 ( 53 ) 150,000 ( 500,000 )1 (1 4 ) 24,600 44,400 83, ,000 2 ( ) ( ) ( )

74 C

75 A B

76 ( ) 7 ( 6 )

77 2 2 (26,440 /)

78 1 300 C ( ) ( )

79 , ,100 ( 3 594,200 / ) (12 ) 18 3 ( ) ( ) ( ) (4 ) 60 ( ) 65 ( )

80 D ( ) ( ) ( ) ( 2 ) E

81 1 ( ) ( 5 ) ( ) (1 )

82 - 77 -

83 - 78 -

84 - 79 -

86 - 81 -

90 - 85 -

91 - 86 -

93 - 88 -

94 - 89 -

96 A

97 - 92 -

98 - 93 -

99 - 94 -

100 - 95 -

101 3 1 -maildf-club@hotmail.co.jp HPhttp://

102 5 101km

103

104 - 99 -

105

106

107

108 5 100km

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123 ( ) 3 1)

124

125

126 2 NPO ,

127

128 ,000 2,

129

130

131

132

133

134

135

136

137

138

139 1. :,., 2005, 18-37, Harvey RJ, Skelton-Robinson M, Rossor MN: The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry, 2003; 74; Sampson EL, Warren JD, Rossor MN: Young onset dementia. Postgrad Med J, 2004; 80; ,, :., 1997; 8; :., 2007; 14; Harvey RJ: Young Onset Dementia: Epidemiology, clinical symptoms, family burden, support and outcome. Imperial College of Science, Technology and Medicine, 1998, :., 2007; 7; ,,,,, :., 2007; 6, Braak H, Braak E: Pathology of Alzheimer disease, Liebson E, Albert MC: Cognitive changes in dementia of Alzheimer type. In Calne DB ed., Neurodegenerative Diseases, WB Saunders Company, 1994, Esiri MM, Hyman BT, Beyreuther K, et al: Aging and dementia, In Graham DI, Lantos PL ed., Greenfield s Neuropathology, 6th ed., Arnold, 1997, Dubois B, Feldman HH, Jacova C, et al: Research criteria for the diagnosis of Alzheimer s disease revising the NINCDS-ADRDA criteria. Lancet Neurol, 2007; 6; The Lund and Manchester Group: Clinical and neuropathological criteria for frontotemporal dementia, J Neurol Neurosurg Psychiatry, 1994; 57; Neary D, Snowden JS, Gustafson L, et al: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 1998; 51; Neary D, Snowden JS, Mann D: Frontotemporal dementia. Lancet Neurol, 2005; 4; Tolnay M, Frank S: Pathology and genetics of frontotemporal lobar

140 degeneration: an update. Clin Neuropathol, 2007; 26; McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, Neurology, 1996; 47; McKeith I, Mintzer J, Aarsland D, et al: Dementia with Lewy bodies. Lancet Neurol, 2004; 3; Lippa CF, Duta JE, Grossman M, et al: DLB and PDD boundary issues; diagnosis, treatment, molecular pathology, and biomakers. Neurology, 2007; 68, Merdes AR, Hansen LA, Jeste DV, et al: Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology, 2003; 60; Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 1993; 43; Kaye JA: Diagnostic challenges in dementia. Neurology, 1998; 51(Suppl 1); S45-S Erkinjuntti T: Vascular cognitive impairment and dementia, In Mohr JP, Choi DW, Grotta JC, et al ed., Stroke, pathophysiology, diagnosis, and management, 5th ed., Churchill Livingstone, 2004, :. 2006, Barber R, Ballard C, McKeith IG, et al: MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology, 2000; 54; Minoshima S, Giordani B, Berent S, et al: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer s disease. Ann Neurol, 1997; 42; Miller BI, Ikonte C, Ponton M, et al: A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations, Neurology, 1997; 48; McNeill R, Sare GM, Manoharen M, et al: Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer disease. J Neurol Neurosurg Psychiatry, 2007; 78; Lobotesis K, Fenwick JD, Phipps A, et al: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 2001; 56; , : ADAS, MMSE, HDS-R, GBS, MENFIS,, 1994; 8;

141 30.,, : Mini-Mental State., 1985; 1; Folstein MF, Folstein SE, Mchugh PR: Mini-Mental State : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975; 12; Andreasen N, Minthon L, Davidsson P, et al: Evaluation of CSF-tau and CSF-A beta 42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol, 2001; 58; Agostini JV, Inouye SK: Delirium. In: Hazzard WR, Blass JP, Halter JB et al ed., Principle of Geriatric Medicine and Gerontology, McGraw Hill, 2003, , :., 2004, , , , :., 1998; 9: McKhann G, Drachman DA, Folstein M, et al: Clinical diagnosis of Alzheimer s disease report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer s disease. Neurology, 1984; 34; :., 2005; 49; Petersen RC, Thomas RG, Grundman M, et al: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med, 2005, 352; Black SE, Doody R, Li H, et al: Donepezil preserves cognition and global function in patient with severe Alzheimer disease. Neurology, 2007; 69; :. Phama Medica, 2003; 21; :., 2006; 17; ,, :., 2004; 15; :., 2004; 15; , :., 2004; 15; Pietro MJS, Ostuni E: Successful Communication with Persons with Alzheimer s Disease (, : ),, 2004,

142 46. :., 2005; 31; Hellen C: Alzheimer s disease; Activity-focused care. Butterworth Heinemann, 1998, 19-42, Volicer L, Hurley A ( ):., 2004, 49-68, : QOL. Medicina, 2007; 44; Ahronheim JC: Nutrition and hydration in the terminal patient. Clinics in Geriatric Medicine, 1996; 12; :., 1995, 43-47, :., 2000, , ,, : -., 2007; 6; Cheston R, Bender M: Understanding dementia. Jessica Kingsley Publisher, 2004, Clare L: Managing threats to self: awareness in early stage Alzheimer s disease. Social Science & Medicine, 2003; 57; , :., 2007; 14; , 2. :, 3,, 2007; :, 3,, 2007; , ,, ,, : : 107(12); ,, : : 15; , : : 107(12);

143 5., : : 41; ,, : : 16; ,, : : 16; ,,,,,,, :. - -, 2007: ,, : : 134; ,, : : 4295; : : 13(3); : : 14(4); ,, : : 31(3); ,, : : 57(5); ,, : ~ ~ : 107(12); ,, : : 14(4); ,, : : 16; Rizzo M, Reinach S, McGhee D, et al.: Simulated car crashes and crash predictors in drivers with Alzheimer disease. Arch Neurol 1997: 54 (5); Hunt LA, Murphy CF, Carr D, et al.: Reliability of the Washington University road test -A performance-based assessment for drivers with dementia of the Alzheimer type-. Arch Neurol 1997: 54 (6); Rizzo M, McGehee DV, Dawson JD, et al.: Simulated Car Crashes at Intersections in Drivers With Alzheimer Disease. Alzheimer Dis Assoc Disord 2001: 15 (1); Ott BR, Heindel WC, Whelihan WM, et al.: Maze test performance and reported driving ability in early dementia. J Geriatr Psychiatry

144 Neurol 2003: 16(3); Wild K, Cotrell V.: Identifying driving impairment in Alzheimer disease: A comparison of self and observer reports versus driving evaluation. Alzheimer Dis Assoc Disord 2003: 17(1); Duchek JM, Carr DB, Hunt L, et al.: Longitudinal driving performance in early-stage dmentia of the Alzheimer type. J Am Geriatr Soc 2003: 51(10); Uc EY, Rizzo M, Anderson SW, et al.: Driver route-following and safety errors in early Alzheimer disease. Neurology 2004: 63 (5); ,, : ; ,, : : 17; :., :., :, :., ,,,,,,,,, : 2007., :, :.,

145 1. :., 4 ; 2007; : : : : :. ; : :., :.,

146

Diagnosis of Dementia: Update

Diagnosis of Dementia: Update 10 C A 1 2 Normal SMI MCI Early Dementia B Moderate Dementia 3 Severe Dementia 4 5 D AD, VD, FTD, DLB, PDD Depression Dementia d/t GMC Modifiable risk factors and preventive factors for dementia 6-5 -